Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
Worth noting: back on screen 3, Gala requires an explicit auto-renewal subscription consent the patient acknowledges up front that each month auto-renews unless cancelled, and that first-month charges happen after provider review
Reddy Laboratories, grants from Novartis, grants and personal fees from PCORI, grants from Scion, grants and personal fees from Teva, grants from Zosano, personal fees from Promius, personal fees from Biohaven, personal fees from Theranica, and grants from Satsuma, outside the submitted work
doi: 10.3390/nu13124359 6